Skip to main content
Vita 34 AG logo

Vita 34 AG — Investor Relations & Filings

Ticker · V3V ISIN · DE000A0BL849 LEI · 529900OEWA4GSZEZ4P40 F Human health and social work activities
Open in API
Filings indexed 794 across all filing types
Latest filing 2016-11-14 Report Publication Anno…
Country DE Germany
Listing F V3V

About Vita 34 AG

https://www.vita34.de/en/

Vita 34 AG is a biobank specializing in the cryopreservation of stem cells derived from umbilical cord blood and tissue. Established in 1997 as the first private cord blood bank in Europe, the company offers services for the long-term storage of perinatal stem cells for potential future medical applications. The service portfolio includes providing collection kits for childbirth, handling logistics, processing the biological material, and storing the stem cell deposits under cryogenic conditions. These services are offered to expectant parents as a form of private medical provision for their child and family. As part of the Famicord Group, Vita 34 is also involved in research and development related to cell-based therapies.

Recent filings

Filing Released Lang Actions
Datum:14.11.2016
Report Publication Announcement Classification · 100% confidence The document is a short notification (under 800 characters) that informs stakeholders about the availability of a quarterly report (Zwischenmitteilung) for the period 30.06.2016 to 30.09.2016. It provides a link to the report and specifies the publication date. Per the 'Menu vs Meal' rule, since this is an announcement of a report's availability rather than the report itself, it is classified as a Report Publication Announcement (RPA).
2016-11-14 German
DGAP-DD: Vita 34 AG english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains the header 'DGAP-DD: Vita 34 AG english' followed by 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details the name of a person in a managerial role (Dr. Holger Födisch, Member of the administrative or supervisory body), the nature of the transaction ('Disposal'), and the price/volume of shares traded. This content directly matches the definition for Director's Dealing.
2016-10-20 English
DGAP-DD: Vita 34 AG english
Director's Dealing Classification · 100% confidence The document explicitly states 'Directors’ Dealings' in the title and contains detailed sections titled 'Details of the person discharging managerial responsibilities' and 'Details of the transaction(s)', including the nature of the transaction ('Disposal') and specific price/volume data. This directly corresponds to the definition of Director's Dealing (insider trades) which is classified as code DIRS.
2016-10-20 English
Vita 34 AG: Innovationsfuhrer Vita 34 begleitet Aufbau einer Stammzellbank in Yinchuan, China
M&A Activity Classification · 99% confidence The document is a news release dated October 20, 2016, announcing a cooperation agreement between Vita 34 AG and AVIC Biology to establish a stem cell bank in China. It uses the header 'DGAP-News' and is distributed via the DGAP service, which typically handles regulatory news and corporate announcements. The content describes a strategic business development (a cooperation/partnership) rather than a formal financial filing like a 10-K, Earnings Release (ER), or Interim Report (IR). Since it is a general corporate announcement about a strategic move that doesn't fit the specific categories like M&A (TAR), Financing (CAP), or Director's Dealing (DIRS), the most appropriate general category for non-standard regulatory news is 'Regulatory Filings' (RNS), which serves as a fallback for miscellaneous announcements. However, given the nature of the announcement—a strategic partnership and expansion—it is a significant corporate event announcement. If 'RNS' is used as a catch-all, it applies. If we look closely at the definitions, none perfectly capture a 'Strategic Partnership Announcement' outside of the financial reporting context. Since it is a news item distributed via a regulatory news service (DGAP), RNS is the best fit as a general regulatory/corporate news announcement.
2016-10-20 German
Vita 34 Receives Patent for the Preparation of Umbilical Cord Tissue for Cryo-Preservation
Regulatory Filings Classification · 100% confidence The document is a short news release dated October 12, 2016, announcing that Vita 34 AG has received a patent for the preparation and cryo-preservation of umbilical cord tissue. It is distributed via DGAP-News and contains standard corporate boilerplate information, including company profile and contact details. It is not a comprehensive financial report (like 10-K or IR), an earnings release (ER), or a management discussion (MDA). Since it is a specific announcement regarding intellectual property/technology, it does not fit neatly into the primary financial categories. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a general corporate news announcement that doesn't match a more specific category like Patent Filing (which is not an option) or a specific financial event. However, since the core content is a specific business development (patent grant), and it is not a standard regulatory filing like a director's dealing or major shareholding change, RNS serves as the best general regulatory/news announcement category available.
2016-10-12 English
Datum:06.09.2016
AGM Information Classification · 100% confidence The document is a short announcement (1217 characters) from Vita 34 AG regarding the dividend distribution decision made at the Annual General Meeting held on August 25, 2016, based on the 2015 annual financial statements. Since it specifically details the dividend amount per share and the allocation of the balance sheet profit, it falls under the category of a dividend announcement.
2016-09-06 German

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.